ESC Premium Access

Introduction - SGLT2 inhibition in diabetes and heart failure: discuss the evidence.

Topic: Diabetes management
Organised by Academic Medical Center Amsterdam. Dept Vascular Medicine and Physicians' Academy for Cardiovascular Education / Course Director: Prof John Kastelein / Supported by an unrestricted educational grant from Boehringer Ingelheim/Lilly

Presentation

About the speaker

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)
16 presentations
0 follower

2 more presentations in this session

SGLT2 inhibition: exploring the evidence in diabetes and heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

Interactive discussion: what are the implications of SGLT2 inhibition in HF patients with diabetes?

Speaker: Doctor D. Fitchett (Toronto, CA) Professor J. McMurray (Glasgow, GB)

Thumbnail

Access the full session

SGLT2 inhibition in diabetes and heart failure: discuss the evidence

Speakers: Doctor D. Fitchett, Professor J. McMurray, Doctor D. Fitchett, Professor J. McMurray
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk